Markus Puhlmann
Chief Tech/Sci/R&D Officer en PERSPECTIVE THERAPEUTICS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Markus Puhlmann is currently the Chief Medical Officer at Perspective Therapeutics, Inc. Prior to his current position, he served as the Head-Global Clinical Development at Seagen Inc. from 2019 to 2022.
Before that, he worked as a Principal at Merck & Co., Inc. from 2015 to 2019.
Dr. Puhlmann holds a doctorate degree from Ludwig-Maximilians-Universität München and an MBA from McDonough School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/04/2024 | 1 375 425 ( 0.23% ) | 2 M $ | 31/03/2024 |
Cargos activos de Markus Puhlmann
| Empresas | Cargo | Inicio |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Markus Puhlmann.
| Empresas | Cargo | Fin |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2019 |
Formación de Markus Puhlmann.
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Markus Puhlmann
